Overview of the Offering
Type of Shares Issued: RMB Ordinary Shares (A Shares)
Par Value per Share: RMB 1.00
Proposed Listing Exchange: Shenzhen Stock Exchange
Issue Price per Share: [ ] RMB/share
Expected Issue Date: [ ] Year [ ] Month [ ] Day
Total Share Capital After Issuance: Not exceeding 16 million shares
The company plans to publicly issue between 3 million and 40 million new shares, with existing shareholders intending to sell up to 37 million shares. The total number of shares offered will not exceed 40 million. Among these, the controlling shareholder intends to sell 1.5 million shares, and shareholders holding more than 10% intend to sell no more than 15.1817 million shares. Directors, supervisors, senior management, and core technical personnel who have served in the past 36 months intend to sell no more than 1.624 million shares. The funds raised from the sale of shares by shareholders will not belong to the company, and investors should consider this when quoting and subscribing.
Lock-up Commitments
Shareholders have made the following commitments regarding the lock-up of shares:
- The controlling shareholder, Jianzhikangye, and actual controllers Hu Bo and Han Xiaohong, along with their associates, commit not to transfer or entrust others to manage the shares held directly or indirectly for 36 months from the date of listing.
- Shareholders Beijing Fukun, Chongqing Fukun, and Shenzhen Yide commit to the same lock-up period.
- Other shareholders, including Beijing Dinghui and Shenzhen Tiantu, commit to a 12-month lock-up period.
- Directors and senior management holding shares indirectly commit to a 12-month lock-up period.
- During their tenure, directors and senior management commit to not transferring more than 25% of their shares annually and not transferring shares within six months after leaving the company.
- The controlling shareholder and relevant directors and senior management commit to not reducing their holdings below the issue price during the two years following the lock-up period.
Issuer's Declaration
The issuer and all directors, supervisors, and senior management commit that the prospectus does not contain false records, misleading statements, or significant omissions, and they bear individual and joint legal responsibility for its authenticity, accuracy, and completeness.
Important Matters
Investors are reminded of the following significant matters:
- Share Circulation Restrictions and Lock-up Commitments: As detailed above.
- No False Records or Misleading Statements: The issuer and its controlling shareholder commit to repurchase shares if any false records or misleading statements are identified.
- Distribution of Retained Earnings: Retained earnings prior to the IPO will be shared by new and existing shareholders based on their shareholding ratios post-issue.
- Dividend Distribution Policy: The company will prioritize reasonable returns to investors while ensuring sustainable development.
Risk Factors
Investors should pay special attention to the following risks:
- Seasonal Performance Fluctuations: The health checkup industry experiences seasonal variations in performance.
- Goodwill Impairment Risk: The company must conduct goodwill impairment tests regularly.
- Expansion Risks: Rapid expansion may affect operational performance.
- Medical Errors: Risks associated with medical errors in health checkups.
- Shareholding Structure Risks: The controlling shareholder's stake may decrease post-IPO.
- Franchise Risks: Risks associated with franchise operations.
- Market Expectations: Predictions regarding industry prospects may not be realized.
- Performance Decline Post-IPO: Various factors may lead to a decline in performance in the year of listing.
Investors are encouraged to carefully read the "Risk Factors" section of the prospectus.
Overview
This overview provides a brief summary of the entire prospectus. Investors should carefully read the full prospectus before making investment decisions.